Why CRISPR Therapeutics AG Jumped 11.7% in June – Madison.com
Madison.com |
Why CRISPR Therapeutics AG Jumped 11.7% in June
Madison.com First, CRISPR and MaSTherCell SA announced that they have signed a development and manufacturing agreement related to allogeneic CAR-T therapies. The deal calls for MaSTherCell to handle the development and manufacturing of CRISPR's compound … CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration CRISPR Therapeutics teams up with Neon Therapeutics to develop T cell therapies Crispr Theraptc (CRSP) Shares Sold by Clough Capital Partners LP |
